Interleukin 6 mediates myocardial fibrosis, concentric hypertrophy, and diastolic dysfunction in rats.
about
Adult cardiac expression of the activating transcription factor 3, ATF3, promotes ventricular hypertrophyCARD9 as a potential target in cardiovascular diseaseThe fibrosis-cell death axis in heart failureA-kinase-anchoring protein-Lbc anchors IκB kinase β to support interleukin-6-mediated cardiomyocyte hypertrophyNatural product derivative BIO promotes recovery after myocardial infarction via unique modulation of the cardiac microenvironmentA comparative multi-parametric in vitro model identifies the power of test conditions to predict the fibrotic tendency of a biomaterial.Blockade of IL-6 Trans signaling attenuates pulmonary fibrosisMacrophage-stimulated cardiac fibroblast production of IL-6 is essential for TGF β/Smad activation and cardiac fibrosis induced by angiotensin IIInvestigating the potential role of TRPA1 in locomotion and cardiovascular control during hypertension.Inflammation and echocardiographic parameters of ventricular hypertrophy in a cohort with preserved cardiac function.Modest elevation in BNP in asymptomatic hypertensive patients reflects sub-clinical cardiac remodeling, inflammation and extracellular matrix changes.Deletion of interleukin-6 prevents cardiac inflammation, fibrosis and dysfunction without affecting blood pressure in angiotensin II-high salt-induced hypertension.Recurrent exposure to subclinical lipopolysaccharide increases mortality and induces cardiac fibrosis in mice.Diastolic dysfunction is associated with an increased risk of contrast-induced nephropathy: a retrospective cohort studyInterleukin-16 promotes cardiac fibrosis and myocardial stiffening in heart failure with preserved ejection fractionDietary salt restriction improves cardiac and adipose tissue pathology independently of obesity in a rat model of metabolic syndrome.Pulmonary delivery of docosahexaenoic acid mitigates bleomycin-induced pulmonary fibrosisMyocardial fibrosis induced by exposure to subclinical lipopolysaccharide is associated with decreased miR-29c and enhanced NOX2 expression in micePKC δ and βII regulate angiotensin II-mediated fibrosis through p38: a mechanism of RV fibrosis in pulmonary hypertension.Substance P induces adverse myocardial remodelling via a mechanism involving cardiac mast cells.Qiliqiangxin inhibits angiotensin II-induced transdifferentiation of rat cardiac fibroblasts through suppressing interleukin-6Relationship between Inflammatory Cytokines and Indices of Cardiac Dysfunction following Intense Endurance ExerciseType 1 diabetes increases the expression of proinflammatory cytokines and adhesion molecules in the artery wall of candidate patients for kidney transplantation.Inhibition of signal transducer and activator of transcription 3 (STAT3) attenuates interleukin-6 (IL-6)-induced collagen synthesis and resultant hypertrophy in rat heart.Anti-Fibrotic Effects of Class I HDAC Inhibitor, Mocetinostat Is Associated with IL-6/Stat3 Signaling in Ischemic Heart Failure.Non-human primate and rat cardiac fibroblasts show similar extracellular matrix-related and cellular adhesion gene responses to substance P.Autonomic neural regulation of the immune system: implications for hypertension and cardiovascular diseaseMesenchymal stem cell-derived inflammatory fibroblasts promote monocyte transition into myeloid fibroblasts via an IL-6-dependent mechanism in the aging mouse heart.Early Regulation of Profibrotic Genes in Primary Human Cardiac Myocytes by Trypanosoma cruzi.Cardiac Dysfunction in the BACHD Mouse Model of Huntington's Disease.Prevention of adverse cardiac remodeling to volume overload in female rats is the result of an estrogen-altered mast cell phenotype.Differential Effects of Prevention and Reversal Treatment with Lisinopril on Left Ventricular Remodelling in a Rat Model of Heart Failure.Human Cardiac Mesenchymal Stromal Cells with CD105+CD34- Phenotype Enhance the Function of Post-Infarction Heart in Mice.β-Adrenergic receptors stimulate interleukin-6 production through Epac-dependent activation of PKCδ/p38 MAPK signalling in neonatal mouse cardiac fibroblastsPressure overload-induced cardiac remodeling and dysfunction in the absence of interleukin 6 in miceTHE AUTOCRINE ROLE OF TRYPTASE IN PRESSURE OVERLOAD-INDUCED MAST CELL ACTIVATION, CHYMASE RELEASE AND CARDIAC FIBROSIS.Role of mitogen-activated protein kinase pathways in multifactorial adverse cardiac remodeling associated with metabolic syndromeChronic treatment of mice with leukemia inhibitory factor does not cause adverse cardiac remodeling but improves heart function.Deletion of interleukin-6 alleviated interstitial fibrosis in streptozotocin-induced diabetic cardiomyopathy of mice through affecting TGFβ1 and miR-29 pathways.Selective improvement in renal function preserved remote myocardial microvascular integrity and architecture in experimental renovascular disease.
P2860
Q27311483-1CDF98CC-9236-4AE0-814B-E02903534991Q28066993-F28DBDDB-4E94-4558-86E2-25272F4CEBBBQ28076570-D21C7F13-5B06-4C61-97D5-5C1350EBF302Q28116093-3E491EF4-17A7-4729-B746-E5EAF4845536Q28597992-FB13C0DE-0380-4C76-B201-EDCEAC07A500Q33687188-D289464E-E17B-4A49-AC73-3F1BC51800EFQ34218604-835A2932-6710-4DDE-AA02-9778AC5FEB67Q34264496-53F16660-9020-43E8-9E3B-089E9E045973Q34292579-C647DC53-3CCC-4943-882F-D7C7B47526FBQ34304640-5FBEA8BF-355B-4B96-9857-ED1E72925F5FQ34477882-92652D35-A826-404A-8848-2485C38FAAC1Q34633337-B5E4D972-505E-4CFC-A701-AD291F839B6CQ34667902-B71B4F64-63DE-48B5-9BD9-5F1E4ECA8A6FQ34816125-99C98089-BC3F-42F1-A578-E4B43BD5D4E9Q34873552-84A89344-99C5-4988-80A2-01699285B239Q35115060-79D408DB-B1D6-491B-A95C-CEF4E85FA69CQ35151307-6EC7B30F-5628-44F9-B176-E25C4A64E630Q35261976-ECD840B7-F499-43C9-B693-3BB86A6D8D89Q35437493-D25BC23A-4C6E-47AD-A7FE-E528A856B32CQ35538215-0ECB081D-0591-437C-A2DB-AF57E93A8A17Q35571961-5DBC6913-C1A8-4741-AFAA-C55A0108B415Q35662458-C40822A2-74C7-4251-9912-0B5C57E909B0Q35688313-6C21DC19-1A55-442E-B6AF-7892340C6144Q35710032-FD5C7DD5-9EE8-4C8C-BAD6-E0EF44C33118Q35723859-D32A68F4-D04D-4E4C-BAAE-023BEA40E4C6Q35821484-5BE94BC6-4C9E-4642-9773-9C9950E8498FQ35856337-2477413D-6D81-413D-A500-4D865CA432C3Q35878968-CE714F0E-3DD6-4518-ADD6-4279C5558D49Q35895021-A7AC0647-80B8-4BD6-91F7-B7E3EBC81111Q35903061-091F6EC6-9C4F-4A5A-90D0-490AC3600FA5Q35965003-05ED6288-340D-4E6D-99F9-CB7548588052Q36042371-EA1D304B-1990-4208-8793-65874A0B3190Q36077608-0C7CE972-C57E-46FF-89DB-ABAB45F067D0Q36159210-149718CB-332D-467A-9B7D-8FFCE4FB5864Q36350716-0171E6C8-C093-4608-8CB6-4AEC5C635D9EQ36407381-20F99222-F6F5-4C52-8BD3-9A0CB419FF99Q36567326-0177BB35-5673-4CBD-B186-F745BD5A96B1Q36677145-9B38BD4C-A836-4F6C-AC7A-84786C4F3267Q36681664-6724EF4E-59DF-4F9C-B7B2-3749A77FEE90Q36799689-709F6AC0-7C02-48F3-A146-FA331D1693FB
P2860
Interleukin 6 mediates myocardial fibrosis, concentric hypertrophy, and diastolic dysfunction in rats.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Interleukin 6 mediates myocard ...... diastolic dysfunction in rats.
@ast
Interleukin 6 mediates myocard ...... diastolic dysfunction in rats.
@en
Interleukin 6 mediates myocard ...... diastolic dysfunction in rats.
@nl
type
label
Interleukin 6 mediates myocard ...... diastolic dysfunction in rats.
@ast
Interleukin 6 mediates myocard ...... diastolic dysfunction in rats.
@en
Interleukin 6 mediates myocard ...... diastolic dysfunction in rats.
@nl
prefLabel
Interleukin 6 mediates myocard ...... diastolic dysfunction in rats.
@ast
Interleukin 6 mediates myocard ...... diastolic dysfunction in rats.
@en
Interleukin 6 mediates myocard ...... diastolic dysfunction in rats.
@nl
P2093
P2860
P1433
P1476
Interleukin 6 mediates myocard ...... diastolic dysfunction in rats.
@en
P2093
Giselle C Meléndez
Gregory L Brower
Jennifer L McLarty
Joseph S Janicki
P2860
P304
P356
10.1161/HYPERTENSIONAHA.109.148635
P407
P50
P577
2010-07-06T00:00:00Z